Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Recent studies have shown that inhibition of Aquaporine-9 channels may ameliorate the bone
degradation process. Pro-bone is an AQ - 9 channels inhibitor. This study is design to
evaluate the safety of Pro-bone.